Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The CONQUER trial (Gadde et al., 2011) enrolled over 2,400 adults with obesity and at least two weight-related comorbidities, demonstrating that participants receiving the higher-dose combination (phentermine 15 mg/topiramate 92 mg) achieved mean weight loss of approximately 910% of baseline body weight at 56 weeks, compared to 12% with placebo
While reducing body mass index (BMI) does reduce the risk of cancer incidence, it is not to the extent that lowering BMI reduces mortality risk
Other antifungal agents, including polyoxins and nikkomycins, act as chitin synthase inhibitors (Li et al., 2011)
Who Should Consider Retatrutide Retatrutide is built for adults with a valid prescription who want advanced peptide support for metabolic health goals
Our findings carry several important clinical implications
US$ 27.06
US$ 20.53
US$ 27.41
